Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.11.05
Korro Bio Q3 EPS $(0.98) Beats $(1.26) Estimate
Benzinga
2026.11.05
Sight Sciences Says Centers For Medicare & Medicaid Services Establishes New Direct Practice Expense Supply Code For Single-Use TearCare SmartLids Component Of TearCare System
Benzinga
2026.11.05
Vericel Q3 EPS $0.27 Beats $0.06 Estimate, Sales $85.371M Beat $77.948M Estimate
Benzinga
2026.11.05
Celsius Stock Gains on Q3 Earnings Beat, Leadership Overhaul
Benzinga
2026.11.05
Zillow Posts Downbeat Q3 Results, Joins HubSpot, Snap And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
Benzinga
2026.11.05
Entrada Therapeutics Q3 EPS $(0.94) Beats $(1.01) Estimate, Sales $905.000K Miss $5.871M Estimate
Benzinga
2026.11.05
BGC Group Q3 Adj. EPS $0.34, Inline, Sales $832.559M Beat $824.830M Estimate
Benzinga
2026.11.05
Arcutis Biotherapeutics Initiates Enrollment In Its INTEGUMENT-3 Trial To Evaluate ZORYVE To Treat Atopic Dermatitis
Benzinga
2026.11.05
Organon To Present New Analysis Of Phase 3 Data Evaluating VTAMA Cream In Patients With Atopic Dermatitis, At 2026 ACAAI Annual Scientific Meeting
Benzinga
2026.11.05
BGC Group Sees Q4 Sales $805.000M-$865.000M vs $831.185M Est
Benzinga
2026.11.05
Novavax Raises FY2026 Sales Guidance from $235.000M-$275.000M to $385.000M-$415.000M vs $380.285M Est
Benzinga
2026.11.05
Ralph Lauren Q2 Adj. EPS $4.64 Beats $4.26 Estimate, Sales $2.183B Beat $2.122B Estimate
Benzinga
2026.11.05
Centuri Holdings Q3 Adj. EPS $0.42 Beats $0.23 Estimate, Sales $1.192B Beat $1.035B Estimate
Benzinga
2026.11.05
Insight Enterprises Q3 Adj. EPS $3.59 Beats $2.85 Estimate, Sales $2.442B Beat $2.146B Estimate
Benzinga
2026.11.05
Tejon Ranch Q3 EPS $0.12 Beats $0.02 Estimate, Sales $22.612M Beat $11.989M Estimate
Benzinga
2026.11.05
OFA Group Announces 1-For-10 Reverse Stock Split, Effective Nov. 10
Benzinga
2026.11.05
CION Invt Q3 EPS $0.25 Misses $0.29 Estimate, Sales $48.305M Miss $48.925M Estimate
Benzinga
2026.11.05
Karyopharm Therapeutic Common Shares To Be Suspended, Effective Nov. 11; To Trade On OTC Under KPTIQ Ticker
Benzinga
2026.11.05
Cantor Fitzgerald Maintains Overweight on Hut 8, Lowers Price Target to $127
Benzinga
2026.11.05
Why Is Joby Aviation Stock Surging Thursday?
Benzinga
2026.11.05
HubSpot Analysts Slash Their Forecasts After Q3 Results
Benzinga
2026.11.05
Wall Street's Most Accurate Analysts Spotlight On 3 Energy Stocks Delivering High-Dividend Yields
Benzinga
2026.11.05
Global Payments Lowers FY2026 GAAP EPS Guidance from $(3.85)-$(3.77) to $(3.90)-$(3.81) vs $(2.94) Est; Lowers FY2026 Sales Guidance from $13.100B-$13.177B to $12.946-$13.023
Benzinga
2026.11.05
Cantor Fitzgerald Maintains Overweight on Progyny, Raises Price Target to $35
Benzinga
2026.11.05
Barclays Downgrades Expro to Equal-Weight, Lowers Price Target to $14
Benzinga
2026.11.05
James Wynn Doubles Down on Bitcoin Crash Call Despite Fresh ETF Inflows
BeInCrypto
2026.11.05
Politicians Fight Data Centers While Betting Your Retirement on Them
Benzinga
2026.11.05
William Blair Downgrades ThredUp to Market Perform
Benzinga
2026.11.05
Cigna Continues To Expect Adjusted EPS Growth Of At Least 10% In 2027 Off Its Run-Rate; 2027 Headwind For Cigna Healthcare Is Exit From The ACA Exchange Business; 2027 Headwind For Pharmacy Benefit Services Is Compression Of Industry Rebate Pools And...
Benzinga
2026.11.05
Aclaris Therapeutics Q3 EPS $(0.12) Beats $(0.16) Estimate, Sales $1.481M Beat $1.298M Estimate
Benzinga
1
...
237
238
239
240
241
242
...
712
>